PREP Audio - IVIG: New Information, New Products
October 2008, Volume 3, No. 10

IVIG: New Information, New Products

IVIG: New Information, New Products

Learning Objectives

  • Recognize the indications for immunoglobulin therapy.
  • Apply immunoglobulin therapy in antibody deficiencies, infection, and autoimmune and inflammatory diseases, including idiopathic thrombocytopeniaurpura.
  • Determine if there is a role for gamma globulin in autism and chronic fatigue syndrome.
  • Outline the products available for immunoglobulin therapy, their routes of administration, and potential side effects.
  • Understand the mechanism of Fc blockade.
IVIG: New Information, New Products

Melvin Berger, MD, PhD, FAAP

Current Source of Funding from Research Grant: Talecris Biotherapeutics.Current Sources of Funding from Speakers’ Bureaus: Talecris Biotherapeutics, Grifols, CSL Behring, FFF Enterprises.Current Sources of Funding from Consulting: Talecris Biotherapeutics, Grifols, CSL Behring, FFF Enterprises.This issue does contain a discussion of unapproved/investigative use of a commercial product/device.

IVIG: New Information, New Products

Mark Ballow, MD

Current Sources of Funding from Speakers’ Bureaus: Talecris Biotherapeutics, CSL Behring.Current Sources of Funding from Consulting: Talecris Biotherapeutics, CSL Behring.This issue does contain a discussion of unapproved/investigative use of a commercial product/device.

IVIG: New Information, New Products

E. Richard Stiehm, MD, FAAP

Dr. Stiehm disclosed no financial relationship relevant to this issue. This issue does not contain a discussion of unapproved/investigative use of a commercial product/device.